VANCOUVER, British Columbia, October 1, 2022 – Alpha-9 Theranostics, Inc. announced today that it has authorized construction of an in-house research facility in Vancouver, British Columbia.

The fit-for-purpose facility will house chemistry, biology and radiochemistry R&D teams, and will accelerate Alpha-9’s discovery efforts for new peptide and small molecule-based radiopharmaceuticals. The facility will house hot cells to develop Alpha-9’s radiolabeling processes at clinical scale for subsequent transfer to the company’s GMP manufacturing partners, facilitating clinical translation of the company’s product candidates. Planning has been underway since earlier this year and the research facilities are expected to be operational by 2H 2023